Semnur Pharmaceuticals entered into a binding term sheet with iHolding Group for a proposed $100 million equity investment. The deal envisions iHolding purchasing approximately 10,000,000 newly issued common shares at $10.00 per share. Closing is subject to due diligence, definitive documentation, board and stockholder approvals, and any required regulatory approvals. There is no assurance the transaction will be completed on these terms or at all.
Agreement details:
- Agreement type: Binding term sheet for $100 million common stock purchase
- Counterparty: iHolding Group
- Signed / Effective: Jul 03 2026 / same
- Reason: Strengthen liquidity and fund growth initiatives
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.